Sunday, August 31, 2014 11:50:10 PM
Product : Bavituximab
CAS# : 648904-28-3
http://webcache.googleusercontent.com/search?q=cache:SSzJUq_2RkYJ:www.parchem.com/chemical-supplier-distributor/Bavituximab-018304.aspx+&cd=1&hl=en&ct=clnk&gl=us
http://www.chemicalbook.com/SupplierMultiProduct.aspx?CBSID=15748&CBNumber=CB51090946
------------------------------------------
http://www.ncebiomed.com/index/search.html
----------------------------------------
Is this common for clinical trial drugs...?
-------------------------------------
Says "Parchem" is a supplier of Bavituximab...
http://www.parchem.com/chemical-supplier-distributor/Bavituximab-018304.aspx
------------------------------------
March 5, 2014
New Rochelle, NY – Parchem - fine & specialty chemicals has spent years cultivating business in the pharmaceutical industry, specifically as the premier supplier of APIs, specialty intermediates, and excipients. Its partnership list includes some of the top global pharmaceutical companies such as Bristol Meyers Squibb, Pfizer, and Boehringer Ingelheim. Parchem’s presence in the pharmaceutical industry market is founded upon a customer-centric, value-driven business model. As an ISO 9001 and NACD Responsible Distribution certified company, Parchem understands the importance of prioritizing quality controls, regulatory compliance, and a commitment to strong partnerships.
Parchem’s new pharmaceutical division will be spearheaded by Cindy Cardona, a well-respected chemical industry expert with a background in marketing and distribution. The newly formed alliance is ideal for both entities and will foster continued success in markets that are growing exponentially. Specifically, the strategy of launching the new division was based on PR being identified as a major hub for a number of leading pharmaceutical companies.
Ephraim Rabin, CEO of Parchem – fine & specialty chemicals, said: “We are excited about the expansion of our new pharmaceutical division being led by Cindy Cardona. She is a consummate professional with a proven track record of success in chemical sales. The new Puerto Rico division is an important part of our sustainability plan that will fuel Parchem’s continued growth in the long term.”
Parchem is the leading global marketer of specialty raw materials to the cosmetic, nutrition, coatings, pharmaceutical, and specialty chemical markets. As a global leader in fine & specialty chemical supply, Parchem has built a worldwide reputation as a vital link in the supply chain. Parchem – fine & specialty chemicals, takes pride in partnering with leaders in the pharmaceutical industry to support solutions for healthcare worldwide.
http://www.socma.com/pressroom/index.cfm?subSec=3&sub=72&articleID=4521
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:31:12 AM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM